Company news
Medicure Inc. news in 2017
Medicure Inc.'s news releases, calls and decks from 2017, newest first.
Medicure Announces FDA Approval Received for Prexxartan®
December 19, 2017
Medicure Acquires Exclusive License to Sell and Market Branded Cardiovascular Drug in the U.S.
December 14, 2017
Medicure Reports Financial Results for Quarter Ended September 30, 2017
November 21, 2017
Medicure Announces Repayment of Outstanding Debt
November 17, 2017
Medicure Q3 Results and Conference Call Dates
November 15, 2017
Medicure Acquires Exclusive License to Sell and Market PREXXARTAN® in the U.S. from Carmel Biosciences
October 31, 2017
Medicure Announces Sale of Apicore Business
October 3, 2017
Medicure Reports Financial Results for Quarter Ended June 30, 2017
August 7, 2017
Medicure Q2 Results and Conference Call Dates
August 2, 2017
Medicure Closes Acquisition of Additional Interests in Apicore
July 12, 2017
Medicure Exercises Option to Acquire Additional Interests in Apicore
July 10, 2017
Medicure Provides Update on Apicore Purchase Option
July 3, 2017
Medicure Reports Financial Results for Quarter Ended March 31, 2017
May 24, 2017
Medicure Q1 Results and Conference Call Dates
May 18, 2017
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2016
April 26, 2017
Medicure to Announce Fiscal Year End 2016 Financial Results on April 26, 2017
March 29, 2017
Medicure Announces FDA Approval for Apicore's Generic Tetrabenazine
March 23, 2017
Medicure Provides Apicore Secured Loan to Replace Knight Loan
January 9, 2017
Decks in 2017
- Investor Presentation (May 2017)
Investor deck · 21 slides · May 24, 2017